本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Aclaris Therapeutics

5.32
-0.1850-3.36%
盤後5.320.00000.00%19:43 EDT
成交量:327.82萬
成交額:1,740.99萬
市值:7.83億
市盈率:-9.08
高:5.60
開:5.50
低:5.17
收:5.51
52周最高:6.60
52周最低:1.74
股本:1.47億
流通股本:1.10億
量比:1.36
換手率:2.98%
股息:- -
股息率:- -
每股收益(TTM):-0.5861
每股收益(LYR):-0.5300
淨資產收益率:-59.10%
總資產收益率:-28.98%
市淨率:6.29
市盈率(LYR):-10.04

資料載入中...

2020/02/12

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/10

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/05

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/04

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/13

重要事件披露

Current report, items 7.01 and 9.01
2020/01/08

重要事件披露

Current report, items 5.02, 7.01, and 9.01
2019/12/19

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/12/03

重要事件披露

Current report, items 7.01 and 9.01
2019/11/21

重要事件披露

Current report, items 7.01 and 9.01
2019/11/21

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/11/07

重要事件披露

Current report, items 2.02 and 9.01
2019/11/07

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/10/31

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/10/17

重要事件披露

Current report, items 1.01 and 9.01
2019/10/15

超過5%披露

General statement of acquisition of beneficial ownership
2019/10/11

重要事件披露

Current report, items 1.01, 1.02, 2.01, 7.01, and 9.01
2019/09/27

重要事件披露

Current report, items 7.01 and 9.01
2019/09/09

重要事件披露

Current report, item 5.02
2019/09/05

重要事件披露

Current report, items 2.05, 7.01, and 9.01